U.S. markets close in 3 hours 32 minutes

Repligen Corporation (RGEN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
198.46+2.94 (+1.50%)
As of 12:27PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close195.52
Bid196.42 x 800
Ask196.87 x 800
Day's Range194.76 - 198.77
52 Week Range110.45 - 211.13
Avg. Volume628,531
Market Cap11.069B
Beta (5Y Monthly)1.03
PE Ratio (TTM)268.19
EPS (TTM)0.74
Earnings DateApr 30, 2024 - May 06, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est204.53
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-58% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for RGEN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Repligen Corporation
    RGEN: Lowering target price to $157.00REPLIGEN CORP has an Investment Rating of SELL; a target price of $157.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more